We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Nanoparticle Method for Rapid Detection of Pathogens

By Biotechdaily staff writers
Posted on 10 Sep 2002
A new diagnostic method based on DNA-coated nanometer-sized gold particles and Raman spectroscopy has been developed to detect infectious disease agents. More...
The technique was described in the August 30, 2002, issue of Science.

Researchers from Northwestern University (Evanston, IL, USA; www. northwestern.edu) have produced detection probes consisting of unique DNA subunits attached to 13 nm gold particles. These probes are used in conjunction with a chip spotted with strands of DNA designed to recognize different pathogenic organisms. If the pathogen is present in the sample being tested, it binds to the appropriate spot on the chip. Corresponding nanoparticle probes then bind to the organism. The chip is washed and then treated with ordinary photographic developing solution. Silver from the developer coats the gold nanoparticles where a match has taken place. The chip is then examined by Raman spectroscopy, and the signals for the probes are recorded. In this fashion a unique fingerprint can be designed for each biologic agent.

Raman spectroscopy is the measurement of the wavelength and intensity of inelastically scattered light from molecules. The Raman scattered light occurs at wavelengths that are shifted from the incident light by the energies of molecular vibrations. The mechanism of Raman scattering is different from that of infrared absorption, and Raman and infrared (IR) spectra provide complementary information. Typical applications are in structure determination, multicomponent qualitative analysis, and quantitative analysis.

"The silver enhances the signal by many orders of magnitude, creating a highly sensitive method for detecting DNA,” explained senior author Dr. Chad A. Mirkin, director of Northwestern University's Institute for Nanotechnology. "By providing a near infinite number of signals, this advance allows researchers to quickly and accurately screen a sample for an extraordinarily large number of diseases simultaneously. Our technique seems to surpass conventional fluorescence-based methods in almost every category -- sensitivity, selectivity, ease of use and speed -- and has the potential to be very inexpensive.”



Related Links:
Northwestern University

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.